威廉·布莱尔精选:2026年五大生物科技股投资标的
The top 5 stock picks for biotech in 2026: William Blair
生物技术与制药领域的最新动态
The top 5 stock picks for biotech in 2026: William Blair
Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 - Yahoo Finance
Gilead's herpes deal; FDA approvals for Boehringer, Roche
Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D
Math Lab Equipment Market Is Going to Boom |Thermo Fisher Scientific • Agilent Technologies - openPR.com
Labcorp backs Cellens in developing physics test aimed at bladder cancer
Notice of email fulfilment change
Voya Investment Management LLC Cuts Stake in Agilent Technologies, Inc. $A - MarketBeat
Spatial Transcriptomics Market Size, Trends & Growth Report by 2034 - Straits Research
Neurocrine’s Ingrezza flunks pivotal study in dyskinetic cerebral palsy
Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 - Insider Monkey
Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 - Yahoo Finance
Shanghai Xianxiang Medical Technology divulges new EGFR degradation inducers
Laekna Pharmaceutical describes new WRN inhibitors
New NLRP3 inhibitors disclosed in Neushen Therapeutics patent
Shandong Simcere Medgenn Bio-Pharmaceutical discovers new CDK4/cyclin D1 inhibitors
Miracle babies, antibiotic improv and T-cell tamers: Fierce's favorite research stories of 2025
Updated: Pfizer discloses patient death in Hympavzi hemophilia trial
Will Agilent’s (A) Native-Read Sequencing Push with Wasatch BioLabs Redefine Its Genomics Narrative? - simplywall.st
Will Agilent’s (A) Native-Read Sequencing Push with Wasatch BioLabs Redefine Its Genomics Narrative? - simplywall.st